KRISTA CHICCARINE: Open Payments
NPI 1417621509 · COLLEGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,555 in 132 payments from 29 companies in 2025. Trend: 2023 $1,995 · 2024 $1,930 · 2025 $2,555
Food & beverage: $2,555
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $306 |
| ABBVIE INC. | 16 | $270 |
| Axsome Therapeutics, Inc. | 10 | $245 |
| Otsuka America Pharmaceutical, Inc. | 9 | $181 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $172 |
| HARMONY BIOSCIENCES LLC | 3 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $139 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $130 |
| Lilly USA, LLC | 5 | $110 |
| Corcept Therapeutics | 4 | $103 |
Products named: REXULTI, VRAYLAR, Sunosi, XIFAXAN, WAKIX, Kerendia, CAPLYTA, Wegovy.
Industry payments across PA — which companies pay providers there.
